| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6814743 | Psychiatry Research | 2014 | 4 Pages |
Abstract
The neurotrophin, brain-derived neurotrophic factor (BDNF), characterises a probable neurobiochemical explanation of maldevelopments in schizophrenia and is a candidate biomarker of the illness. A paucity of studies examining neurobiochemical predictors of remission in schizophrenia exists. In this study, we seek to examine if serum BDNF level is associated with remission status in a sample of Chinese patients with schizophrenia. This study did not find a significant relationship between serum BDNF and remission in patients with schizophrenia. Identification of a suitable biomarker for diagnosis, management, and prognostic outcome is crucial and warrants further study.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Vidhya Renjan, Milawaty Nurjono, Jimmy Lee,